Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias


CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

Online
ISSN
1553-3840
See all formats and pricing
More options …

The effects of Vitex agnus-castus on menstrual bleeding: A systematic review and meta-analysis

Sanaz Mollazadeh
  • Department of Midwifery, Students Research Committee, Faculty of Nursing and Midwifery, Tabriz University of Medical sciences, Tabriz, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mojgan Mirghafourvand
  • Corresponding author
  • Social determinants of Health Research Center, Tabriz University of Medical sciences, Tabriz, Iran
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nafiseh Ghassab Abdollahi
  • Department of Midwifery, Students Research Committee, Faculty of Nursing and Midwifery, Tabriz University of Medical sciences, Tabriz, Iran
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-07-31 | DOI: https://doi.org/10.1515/jcim-2018-0053

Abstract

Introduction

Vitex agnus-castus, also called Vitex, is a plant with many medicinal properties. This systematic study examined the evidence of the effectiveness and safety of Vitex on menstrual bleeding (primary outcome) and its side effects (secondary outcomes).

Materials and methods

This systematic review study examined all papers that were a randomized controlled trial, quasi-experimental, and cross-over conducted on the effect of Vitex on menstrual bleeding, following the PICO (population, intervention, control, and outcomes) criteria without any time limits in December 2017. The participants were women of reproductive age with no gynecologic disorders. The intervention included the use of Vitex in form of tablets, capsule, or oral drops with different doses. The control group included the placebo or mefenamic acid group. The search strategy in this study was in accordance with MeSH terms. The keywords used separately or in combination with other words were Menstrual bleeding OR Menstruation OR Menorrhagia AND Vitexcastus OR Vitex OR Chasteberry AND randomized controlled trial OR randomized trial OR randomized clinical trial OR randomized controlled. All papers, including Persian or English, were searched for in the databases; Medline (through PubMed), Scopus, Embase (through Ovid), Cochrane Library, Web of Sciences, Google Scholar, SID, Magiran, Irandoc, and Iranmedex, without any time limits. Two authors independently reviewed the quality of the papers and assessed the risk of bias based on Cochrane handbook, and the disputes were resolved through discussion and consensus with a third person. The meta-analysis was done on continuous data (mean of menstrual bleeding). In meta-analysis, subgroup analysis was performed based on the type of comparison group.

Results

Out of the 8,905 searched papers in the databases, 8,905 titles, 720 abstracts, 85 full texts, and 20 references of the papers were reviewed, of which 5 papers entered this study. Based on the subgroup analysis, the consumption of Vitex did not have a significant effect on the amount of menstrual bleeding compared to the placebo group in the first (mean difference [MD]: 3.08; 95% CI: −3.11–9.26; p=0.33; I2=0%) and second menstrual cycles (MD: 0.00; 95% CI: −5.75–5.75; p=1.00; I2=0%). Also, the Higham mean score was statistically more in the Vitex group compared to the mefenamic acid group in the first menstrual cycle (MD: 7.17; 95% CI: 0.33–14.01; p=0.04; I2=0%) but there was no statistical significant difference between Vitex and mefenamic acid groups in the second menstrual cycle (MD: 12.18; 95% CI: −5.57–29.94; p=0.18; I2=75%). Only nausea and abdominal pain were reported as side effects of Vitex in the included studies.

Conclusions

The results of this study showed that the consumption of Vitex in the intervention group did not have a significant effect on menstrual bleeding in comparison with the placebo group. However, due to the relatively low quality of the papers, it is essential to perform clinical trials with an appropriate design to determine the effect of Vitex on menstrual bleeding.

Keywords: menstrual bleeding; menstruation; meta-analysis; RCT; systematic review; Vitexcastus

References

  • [1]

    Peyvandi F, Garagiola I, Menegatti M. Gynecological and obstetrical manifestations of inherited bleeding disorders in women. J Thromb Haemost 2011;9:236–45.CrossrefWeb of SciencePubMedGoogle Scholar

  • [2]

    Finch CA, Cook J, Labbe R, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50:441–7.PubMedGoogle Scholar

  • [3]

    Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183–94.Web of ScienceCrossrefPubMedGoogle Scholar

  • [4]

    Willman EA, Collins W, Clayton S. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. BJOG 1976;83:337–41.CrossrefGoogle Scholar

  • [5]

    Madhra M, Fraser IS, Munro MG, Critchley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand 2014;93:619–25.Web of SciencePubMedCrossrefGoogle Scholar

  • [6]

    Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;4:CD000400.Web of ScienceGoogle Scholar

  • [7]

    Romm A. Botanical medicine for women’s health. St Louis, Mo: Churchill Livingstone/Elsevier, 2010.Google Scholar

  • [8]

    Miraj S, Rafieian-Kopaei, Kiani S. Melissa officinalis L: a review study with an antioxidant prospective. J Evid Based Complementary Altern Med 2017;22:385–94.CrossrefGoogle Scholar

  • [9]

    Dennehy CE. The use of herbs and dietary supplements in gynecology: an evidence-based review. JMWH 2006;51:402–9.PubMedGoogle Scholar

  • [10]

    Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)–pharmacology and clinical indications. Phytomedicine 2003;10:348–57.CrossrefPubMedGoogle Scholar

  • [11]

    Donald J, Brown N. Vitexclinical monograph. Med Ser 1994;45:132–7.Google Scholar

  • [12]

    Yavarikia P, Shahnazi M, Mirzaie SH, Javadzadeh Y, Lutfi R. Comparing the effect of mefenamic acid and Vitexon intrauterine device induced bleeding. J Caring Sci 2013;2:245.PubMedGoogle Scholar

  • [13]

    Zamani M, Mansour GM, Farimani M, Nasr ES. Efficacy of mefenamic acid and Vitex in reduction of menstrual blood loss and HB changes in patients with a complaint of menorrhagia. Iran J Obstet Gynecol Infertil 2007;10:79–86.Google Scholar

  • [14]

    Daniele C, Coon JT, Pittler MH, Ernst E. Vitexcastus. Drug Saf 2005;28:319–32.Google Scholar

  • [15]

    Shahhosseini Z, Amin G, Danesh M, Abedian K. Double blind study of anti primary dysmenorrhea effects of vitagnus. J Mazandaran Univ Med Sci 2005;15:15–21.Google Scholar

  • [16]

    Shobeiri F, Zeraati F, Mansouri Z, Araghchian M, Nazari M. The comparative effect of herbal extract of vitagnus and mefenamic acid on primary dysmenorrhea. Zahedan J Res Med Sci 2012;14:30–3.Google Scholar

  • [17]

    Schulz V, Hänsel R, Tyler VE. The 100 most commonly prescribed herbal medications in Germany. In: Rational phytotherapy. Springer, Berlin, Heidelberg: Springer, 1998:287–92.Google Scholar

  • [18]

    Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejak J, Teucher T, et al. Vitexcastus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 1993;43:752–6.PubMedGoogle Scholar

  • [19]

    Ryu A, Kim TH. Premenstrual syndrome: a mini review. Maturitas 2015;82:436–40.Web of ScienceCrossrefPubMedGoogle Scholar

  • [20]

    Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitexcastus extract in the treatment of remenstrual dysphoric disorderp. Hum Psychopharmacol 2003;18:191–5.CrossrefPubMedGoogle Scholar

  • [21]

    Shobeiri F, Zeraati F, Araghchian M, Nazari M. The effect of fennelin, vitagnus and mefenamic acid in the treatment of menstrual bleeding. Sci J Hamadan Univ Med Sci 2014;21:171–6.Google Scholar

  • [22]

    Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Ahmadpour P, Javadzadeh Y. Effects of Vitexand Flaxseed on cyclic mastalgia: a randomized controlled trial. Complement Ther Med 2016;24:90–5.CrossrefPubMedGoogle Scholar

  • [23]

    van Die MD, Burger HG, Bone KM, Cohen MM, Teede HJ. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause 2009;16:156–63.Web of ScienceCrossrefPubMedGoogle Scholar

  • [24]

    Daniele C, Thompson Coon J, Pittler MH, Ernst E. Vitexcastus: a systematic review of adverse events. Drug Saf 2005;28:319–32.PubMedGoogle Scholar

  • [25]

    Dugoua JJ, Seely D, Perri D, Koren G, Mills E. Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. Can J Clin Pharmacol 2008;15:e74–9.PubMedGoogle Scholar

  • [26]

    Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitexcastus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Women’s Mental Health 2017;20:713–19.CrossrefGoogle Scholar

  • [27]

    Maleki-Saghooni N, Karimi FZ, Moghadam ZB, Najmabadi KM. The effectiveness and safety of Iranian herbal medicines for treatment of premenstrual syndrome: A systematic review. Avicenna J Phytomedicine 2018;8:96.Google Scholar

  • [28]

    Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of Vitexcastus: a systematic review and meta-analysis. Am J Obstet Gynecol 2017;217:150–66.CrossrefPubMedGoogle Scholar

  • [29]

    Rafieian-Kopaei M, Movahedi M. Systematic review of premenstrual, postmenstrual and infertility disorders of VitexCastus. Electron Physician 2017;9:3685.PubMedCrossrefGoogle Scholar

  • [30]

    van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med 2013;79:562–75.Web of SciencePubMedGoogle Scholar

  • [31]

    Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. United Kingdom, England: John Wiley & Sons, 2011.Google Scholar

  • [32]

    Mirghafourvand M, Mohammad Alizadeh charandabi S, Javadzadeh Y, Ahmadpour P. The effect of Vitexand flaxseed on the menstrual bleeding: a randomized controlled trial. ZUMS J 2015;23:1–12.Google Scholar

About the article

Received: 2018-04-13

Accepted: 2019-04-02

Published Online: 2019-07-31


There was no financial support source for this study.


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Ethical statement: Primary data for human nor for animals were not collected for this research work.


Citation Information: Journal of Complementary and Integrative Medicine, 20180053, ISSN (Online) 1553-3840, DOI: https://doi.org/10.1515/jcim-2018-0053.

Export Citation

© 2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in